DAPAGLIFLOZIN VERSUS SULFONYLUREA AS AN ADD-ON THERAPY TO METFORMIN- A COST-EFFECTIVENESS ANALYSIS IN COSTA RICA

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1296
https://www.valueinhealthjournal.com/article/S1098-3015(16)01364-4/fulltext
Title : DAPAGLIFLOZIN VERSUS SULFONYLUREA AS AN ADD-ON THERAPY TO METFORMIN- A COST-EFFECTIVENESS ANALYSIS IN COSTA RICA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01364-4&doi=10.1016/j.jval.2016.03.1296
First page : A202
Section Title : Diabetes/Endocrine Disorders - Cost Studies
Open access? : No
Section Order : 634
Categories :
Tags :
Regions :
ViH Article Tags :